Business Description
Edesa Biotech is a Canadian biopharmaceutical company focused on developing treatments for inflammatory and immune-related conditions, with a pipeline that includes both injectable antibody therapies and topical creams. Its most advanced programs target serious conditions such as acute respiratory distress syndrome, chronic skin allergies, and pulmonary fibrosis, with several candidates already in late-stage clinical trials. The company works alongside research partners in Switzerland and Israel to broaden the reach of its drug development efforts across human and animal health applications. Founded in 2015 and based in Markham, Ontario, Edesa continues to advance its portfolio from early research through to potential commercialization.
